nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0726	0.123	CbGbCtD
Zalcitabine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0726	0.123	CbGbCtD
Zalcitabine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0664	0.113	CbGbCtD
Zalcitabine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0664	0.113	CbGbCtD
Zalcitabine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0592	0.1	CbGbCtD
Zalcitabine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0557	0.0944	CbGbCtD
Zalcitabine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.055	0.0933	CbGbCtD
Zalcitabine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0376	0.0638	CbGbCtD
Zalcitabine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0359	0.0609	CbGbCtD
Zalcitabine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.032	0.0542	CbGbCtD
Zalcitabine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0188	0.0318	CbGbCtD
Zalcitabine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0177	0.0301	CbGbCtD
Zalcitabine—DCK—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	0.0008	0.257	CbGdCrCtD
Zalcitabine—DCK—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	0.000781	0.251	CbGdCrCtD
Zalcitabine—DCK—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.000777	0.249	CbGdCrCtD
Zalcitabine—DCK—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.000758	0.243	CbGdCrCtD
Zalcitabine—CYP3A43—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000602	0.00891	CbGpPWpGaD
Zalcitabine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000591	0.00875	CbGpPWpGaD
Zalcitabine—CYP3A43—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000529	0.00784	CbGpPWpGaD
Zalcitabine—CYP3A43—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000523	0.00775	CbGpPWpGaD
Zalcitabine—CYP3A5—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00052	0.00771	CbGpPWpGaD
Zalcitabine—SLC29A1—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000511	0.00757	CbGpPWpGaD
Zalcitabine—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000509	0.00754	CbGpPWpGaD
Zalcitabine—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000505	0.00748	CbGpPWpGaD
Zalcitabine—CYP3A5—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.0005	0.00741	CbGpPWpGaD
Zalcitabine—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00049	0.00725	CbGpPWpGaD
Zalcitabine—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000485	0.00719	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000463	0.00686	CbGpPWpGaD
Zalcitabine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000458	0.00679	CbGpPWpGaD
Zalcitabine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000442	0.00655	CbGpPWpGaD
Zalcitabine—CYP3A43—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00044	0.00651	CbGpPWpGaD
Zalcitabine—CYP3A43—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000434	0.00642	CbGpPWpGaD
Zalcitabine—CYP3A7—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000421	0.00623	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000413	0.00611	CbGpPWpGaD
Zalcitabine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000411	0.00609	CbGpPWpGaD
Zalcitabine—CYP3A7—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000406	0.00601	CbGpPWpGaD
Zalcitabine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000398	0.00589	CbGpPWpGaD
Zalcitabine—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000378	0.0056	CbGpPWpGaD
Zalcitabine—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00037	0.00548	CbGpPWpGaD
Zalcitabine—CYP3A43—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000367	0.00543	CbGpPWpGaD
Zalcitabine—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000367	0.00543	CbGpPWpGaD
Zalcitabine—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000362	0.00536	CbGpPWpGaD
Zalcitabine—CYP3A43—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000362	0.00536	CbGpPWpGaD
Zalcitabine—Cough—Montelukast—chronic obstructive pulmonary disease	0.000361	0.00106	CcSEcCtD
Zalcitabine—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000359	0.00106	CcSEcCtD
Zalcitabine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000359	0.00106	CcSEcCtD
Zalcitabine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000359	0.00106	CcSEcCtD
Zalcitabine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000359	0.00106	CcSEcCtD
Zalcitabine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000359	0.00106	CcSEcCtD
Zalcitabine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000359	0.00106	CcSEcCtD
Zalcitabine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000359	0.00106	CcSEcCtD
Zalcitabine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000358	0.00106	CcSEcCtD
Zalcitabine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000358	0.00105	CcSEcCtD
Zalcitabine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000358	0.00105	CcSEcCtD
Zalcitabine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000358	0.00105	CcSEcCtD
Zalcitabine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000358	0.00105	CcSEcCtD
Zalcitabine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000358	0.00105	CcSEcCtD
Zalcitabine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000357	0.00105	CcSEcCtD
Zalcitabine—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000356	0.00527	CbGpPWpGaD
Zalcitabine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000355	0.00105	CcSEcCtD
Zalcitabine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000355	0.00105	CcSEcCtD
Zalcitabine—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000353	0.00522	CbGpPWpGaD
Zalcitabine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000352	0.00104	CcSEcCtD
Zalcitabine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000352	0.00104	CcSEcCtD
Zalcitabine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000352	0.00104	CcSEcCtD
Zalcitabine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000351	0.00104	CcSEcCtD
Zalcitabine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000351	0.00104	CcSEcCtD
Zalcitabine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000351	0.00103	CcSEcCtD
Zalcitabine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00035	0.00103	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000349	0.00103	CcSEcCtD
Zalcitabine—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000348	0.00102	CcSEcCtD
Zalcitabine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000348	0.00102	CcSEcCtD
Zalcitabine—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000347	0.00102	CcSEcCtD
Zalcitabine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000347	0.00514	CbGpPWpGaD
Zalcitabine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00101	CcSEcCtD
Zalcitabine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00101	CcSEcCtD
Zalcitabine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000344	0.00101	CcSEcCtD
Zalcitabine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000342	0.00101	CcSEcCtD
Zalcitabine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000342	0.00101	CcSEcCtD
Zalcitabine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.000999	CcSEcCtD
Zalcitabine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.000999	CcSEcCtD
Zalcitabine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000339	0.000999	CcSEcCtD
Zalcitabine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.000996	CcSEcCtD
Zalcitabine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000337	0.000994	CcSEcCtD
Zalcitabine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000337	0.000994	CcSEcCtD
Zalcitabine—CYP3A43—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000337	0.00499	CbGpPWpGaD
Zalcitabine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000336	0.00099	CcSEcCtD
Zalcitabine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000336	0.00099	CcSEcCtD
Zalcitabine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000335	0.000988	CcSEcCtD
Zalcitabine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000335	0.000987	CcSEcCtD
Zalcitabine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000335	0.000986	CcSEcCtD
Zalcitabine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000335	0.000986	CcSEcCtD
Zalcitabine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000335	0.000986	CcSEcCtD
Zalcitabine—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000333	0.00494	CbGpPWpGaD
Zalcitabine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000333	0.000982	CcSEcCtD
Zalcitabine—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000333	0.00493	CbGpPWpGaD
Zalcitabine—CYP3A43—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000332	0.00492	CbGpPWpGaD
Zalcitabine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000332	0.000978	CcSEcCtD
Zalcitabine—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000331	0.000976	CcSEcCtD
Zalcitabine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00033	0.000973	CcSEcCtD
Zalcitabine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00033	0.00489	CbGpPWpGaD
Zalcitabine—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00033	0.000973	CcSEcCtD
Zalcitabine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000328	0.000965	CcSEcCtD
Zalcitabine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000326	0.000962	CcSEcCtD
Zalcitabine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.000958	CcSEcCtD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000325	0.00481	CbGpPWpGaD
Zalcitabine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000323	0.000952	CcSEcCtD
Zalcitabine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000322	0.000947	CcSEcCtD
Zalcitabine—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00032	0.00474	CbGpPWpGaD
Zalcitabine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00032	0.000943	CcSEcCtD
Zalcitabine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.000943	CcSEcCtD
Zalcitabine—CYP3A43—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.00032	0.00473	CbGpPWpGaD
Zalcitabine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000319	0.000941	CcSEcCtD
Zalcitabine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000317	0.000935	CcSEcCtD
Zalcitabine—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000317	0.000934	CcSEcCtD
Zalcitabine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.000931	CcSEcCtD
Zalcitabine—CYP3A43—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000315	0.00467	CbGpPWpGaD
Zalcitabine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000314	0.000926	CcSEcCtD
Zalcitabine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.000926	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000314	0.000925	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000314	0.000925	CcSEcCtD
Zalcitabine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000311	0.000918	CcSEcCtD
Zalcitabine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.000918	CcSEcCtD
Zalcitabine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00031	0.000913	CcSEcCtD
Zalcitabine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00031	0.000912	CcSEcCtD
Zalcitabine—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000308	0.000908	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000307	0.000906	CcSEcCtD
Zalcitabine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000307	0.000905	CcSEcCtD
Zalcitabine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000307	0.000905	CcSEcCtD
Zalcitabine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000306	0.000902	CcSEcCtD
Zalcitabine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.000902	CcSEcCtD
Zalcitabine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000305	0.000899	CcSEcCtD
Zalcitabine—CYP3A5—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000304	0.0045	CbGpPWpGaD
Zalcitabine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000303	0.000893	CcSEcCtD
Zalcitabine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000303	0.000893	CcSEcCtD
Zalcitabine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000302	0.00089	CcSEcCtD
Zalcitabine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.0003	0.000884	CcSEcCtD
Zalcitabine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000299	0.000882	CcSEcCtD
Zalcitabine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000299	0.00443	CbGpPWpGaD
Zalcitabine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000297	0.0044	CbGpPWpGaD
Zalcitabine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000297	0.000875	CcSEcCtD
Zalcitabine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000297	0.000875	CcSEcCtD
Zalcitabine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000297	0.000875	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000296	0.000873	CcSEcCtD
Zalcitabine—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000295	0.00437	CbGpPWpGaD
Zalcitabine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000295	0.000868	CcSEcCtD
Zalcitabine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000295	0.000868	CcSEcCtD
Zalcitabine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000294	0.000867	CcSEcCtD
Zalcitabine—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000294	0.000865	CcSEcCtD
Zalcitabine—CYP3A5—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000293	0.00435	CbGpPWpGaD
Zalcitabine—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000293	0.00434	CbGpPWpGaD
Zalcitabine—SLC22A7—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000291	0.00432	CbGpPWpGaD
Zalcitabine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000291	0.000857	CcSEcCtD
Zalcitabine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.000854	CcSEcCtD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00029	0.00429	CbGpPWpGaD
Zalcitabine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000289	0.00428	CbGpPWpGaD
Zalcitabine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.000852	CcSEcCtD
Zalcitabine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000288	0.00085	CcSEcCtD
Zalcitabine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000288	0.000848	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000287	0.000845	CcSEcCtD
Zalcitabine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.000843	CcSEcCtD
Zalcitabine—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000286	0.000843	CcSEcCtD
Zalcitabine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000285	0.000841	CcSEcCtD
Zalcitabine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000285	0.00084	CcSEcCtD
Zalcitabine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000284	0.000836	CcSEcCtD
Zalcitabine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000284	0.000836	CcSEcCtD
Zalcitabine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000283	0.000835	CcSEcCtD
Zalcitabine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000283	0.000833	CcSEcCtD
Zalcitabine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000283	0.000833	CcSEcCtD
Zalcitabine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000282	0.000831	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000282	0.00083	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.00083	CcSEcCtD
Zalcitabine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.000826	CcSEcCtD
Zalcitabine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.000819	CcSEcCtD
Zalcitabine—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000278	0.00411	CbGpPWpGaD
Zalcitabine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000276	0.000813	CcSEcCtD
Zalcitabine—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000276	0.000813	CcSEcCtD
Zalcitabine—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000276	0.000813	CcSEcCtD
Zalcitabine—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000275	0.00407	CbGpPWpGaD
Zalcitabine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000274	0.000806	CcSEcCtD
Zalcitabine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.000806	CcSEcCtD
Zalcitabine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.000802	CcSEcCtD
Zalcitabine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.000802	CcSEcCtD
Zalcitabine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000272	0.000802	CcSEcCtD
Zalcitabine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000272	0.000802	CcSEcCtD
Zalcitabine—SLC29A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000272	0.00402	CbGpPWpGaD
Zalcitabine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000271	0.0008	CcSEcCtD
Zalcitabine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000271	0.000799	CcSEcCtD
Zalcitabine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000269	0.000794	CcSEcCtD
Zalcitabine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000269	0.000793	CcSEcCtD
Zalcitabine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000269	0.000792	CcSEcCtD
Zalcitabine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000268	0.00079	CcSEcCtD
Zalcitabine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.00079	CcSEcCtD
Zalcitabine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000267	0.000788	CcSEcCtD
Zalcitabine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000267	0.000786	CcSEcCtD
Zalcitabine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000267	0.000786	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.000784	CcSEcCtD
Zalcitabine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000263	0.0039	CbGpPWpGaD
Zalcitabine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000261	0.00077	CcSEcCtD
Zalcitabine—DCK—Metabolism—APIP—chronic obstructive pulmonary disease	0.000261	0.00387	CbGpPWpGaD
Zalcitabine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.000761	CcSEcCtD
Zalcitabine—CYP3A43—Metabolism—APIP—chronic obstructive pulmonary disease	0.000257	0.00381	CbGpPWpGaD
Zalcitabine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.000757	CcSEcCtD
Zalcitabine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.000757	CcSEcCtD
Zalcitabine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000254	0.000748	CcSEcCtD
Zalcitabine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000254	0.000748	CcSEcCtD
Zalcitabine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000253	0.000745	CcSEcCtD
Zalcitabine—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000253	0.000745	CcSEcCtD
Zalcitabine—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000251	0.000739	CcSEcCtD
Zalcitabine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000249	0.000732	CcSEcCtD
Zalcitabine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000247	0.000728	CcSEcCtD
Zalcitabine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.000728	CcSEcCtD
Zalcitabine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000244	0.000718	CcSEcCtD
Zalcitabine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000244	0.000718	CcSEcCtD
Zalcitabine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000243	0.000717	CcSEcCtD
Zalcitabine—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000243	0.00359	CbGpPWpGaD
Zalcitabine—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000242	0.00359	CbGpPWpGaD
Zalcitabine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000242	0.000713	CcSEcCtD
Zalcitabine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000242	0.00358	CbGpPWpGaD
Zalcitabine—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000241	0.00357	CbGpPWpGaD
Zalcitabine—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.00024	0.000707	CcSEcCtD
Zalcitabine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.000706	CcSEcCtD
Zalcitabine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000239	0.000703	CcSEcCtD
Zalcitabine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.000694	CcSEcCtD
Zalcitabine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000236	0.000694	CcSEcCtD
Zalcitabine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000235	0.000691	CcSEcCtD
Zalcitabine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000234	0.000689	CcSEcCtD
Zalcitabine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.000687	CcSEcCtD
Zalcitabine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000233	0.00345	CbGpPWpGaD
Zalcitabine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000232	0.000684	CcSEcCtD
Zalcitabine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000231	0.00068	CcSEcCtD
Zalcitabine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.000678	CcSEcCtD
Zalcitabine—SLC29A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00023	0.00341	CbGpPWpGaD
Zalcitabine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000228	0.000671	CcSEcCtD
Zalcitabine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000228	0.000671	CcSEcCtD
Zalcitabine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000223	0.000657	CcSEcCtD
Zalcitabine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000223	0.000657	CcSEcCtD
Zalcitabine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.000656	CcSEcCtD
Zalcitabine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000219	0.000645	CcSEcCtD
Zalcitabine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000219	0.000645	CcSEcCtD
Zalcitabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000218	0.00323	CbGpPWpGaD
Zalcitabine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.00064	CcSEcCtD
Zalcitabine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000217	0.00064	CcSEcCtD
Zalcitabine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000217	0.000639	CcSEcCtD
Zalcitabine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000217	0.000639	CcSEcCtD
Zalcitabine—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000216	0.0032	CbGpPWpGaD
Zalcitabine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000216	0.0032	CbGpPWpGaD
Zalcitabine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000216	0.000636	CcSEcCtD
Zalcitabine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.000636	CcSEcCtD
Zalcitabine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000216	0.000635	CcSEcCtD
Zalcitabine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000215	0.000635	CcSEcCtD
Zalcitabine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.000634	CcSEcCtD
Zalcitabine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000215	0.000633	CcSEcCtD
Zalcitabine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000214	0.000632	CcSEcCtD
Zalcitabine—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000214	0.00318	CbGpPWpGaD
Zalcitabine—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000213	0.00316	CbGpPWpGaD
Zalcitabine—CYP3A7—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000213	0.00316	CbGpPWpGaD
Zalcitabine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000213	0.000627	CcSEcCtD
Zalcitabine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000212	0.000626	CcSEcCtD
Zalcitabine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000212	0.000625	CcSEcCtD
Zalcitabine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000212	0.000624	CcSEcCtD
Zalcitabine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000211	0.00313	CbGpPWpGaD
Zalcitabine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000211	0.000623	CcSEcCtD
Zalcitabine—CYP3A7—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000211	0.00312	CbGpPWpGaD
Zalcitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00021	0.0031	CbGpPWpGaD
Zalcitabine—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000209	0.00309	CbGpPWpGaD
Zalcitabine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000208	0.000614	CcSEcCtD
Zalcitabine—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000207	0.00306	CbGpPWpGaD
Zalcitabine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.000609	CcSEcCtD
Zalcitabine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.000607	CcSEcCtD
Zalcitabine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000205	0.000605	CcSEcCtD
Zalcitabine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.000604	CcSEcCtD
Zalcitabine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000205	0.000604	CcSEcCtD
Zalcitabine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.000604	CcSEcCtD
Zalcitabine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.0006	CcSEcCtD
Zalcitabine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.000592	CcSEcCtD
Zalcitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	0.000198	0.00293	CbGpPWpGaD
Zalcitabine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000198	0.000583	CcSEcCtD
Zalcitabine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000197	0.000581	CcSEcCtD
Zalcitabine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000192	0.000566	CcSEcCtD
Zalcitabine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000559	CcSEcCtD
Zalcitabine—SLC29A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000188	0.00279	CbGpPWpGaD
Zalcitabine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.00055	CcSEcCtD
Zalcitabine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.000541	CcSEcCtD
Zalcitabine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.000536	CcSEcCtD
Zalcitabine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.000531	CcSEcCtD
Zalcitabine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000178	0.000525	CcSEcCtD
Zalcitabine—CYP3A7—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000177	0.00262	CbGpPWpGaD
Zalcitabine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000522	CcSEcCtD
Zalcitabine—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000176	0.00261	CbGpPWpGaD
Zalcitabine—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000175	0.00259	CbGpPWpGaD
Zalcitabine—CYP3A7—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000175	0.00259	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000173	0.00256	CbGpPWpGaD
Zalcitabine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000171	0.00254	CbGpPWpGaD
Zalcitabine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000171	0.00253	CbGpPWpGaD
Zalcitabine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000502	CcSEcCtD
Zalcitabine—CYP3A43—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00017	0.00252	CbGpPWpGaD
Zalcitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00017	0.00252	CbGpPWpGaD
Zalcitabine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000169	0.000497	CcSEcCtD
Zalcitabine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000169	0.000497	CcSEcCtD
Zalcitabine—DCK—Metabolism—GC—chronic obstructive pulmonary disease	0.000168	0.00249	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GC—chronic obstructive pulmonary disease	0.000166	0.00245	CbGpPWpGaD
Zalcitabine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.00047	CcSEcCtD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000159	0.00236	CbGpPWpGaD
Zalcitabine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000461	CcSEcCtD
Zalcitabine—DCK—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000156	0.00232	CbGpPWpGaD
Zalcitabine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000454	CcSEcCtD
Zalcitabine—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000154	0.00228	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000154	0.00228	CbGpPWpGaD
Zalcitabine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.000453	CcSEcCtD
Zalcitabine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000154	0.00228	CbGpPWpGaD
Zalcitabine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000452	CcSEcCtD
Zalcitabine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000153	0.00045	CcSEcCtD
Zalcitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000152	0.00226	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000152	0.00226	CbGpPWpGaD
Zalcitabine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000152	0.00225	CbGpPWpGaD
Zalcitabine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00015	0.00223	CbGpPWpGaD
Zalcitabine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.00015	0.000441	CcSEcCtD
Zalcitabine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000149	0.00044	CcSEcCtD
Zalcitabine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000439	CcSEcCtD
Zalcitabine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.000437	CcSEcCtD
Zalcitabine—CYP3A7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000148	0.00219	CbGpPWpGaD
Zalcitabine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000146	0.00043	CcSEcCtD
Zalcitabine—CYP3A7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000146	0.00216	CbGpPWpGaD
Zalcitabine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000424	CcSEcCtD
Zalcitabine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000422	CcSEcCtD
Zalcitabine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000141	0.00209	CbGpPWpGaD
Zalcitabine—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000417	CcSEcCtD
Zalcitabine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000417	CcSEcCtD
Zalcitabine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000415	CcSEcCtD
Zalcitabine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000412	CcSEcCtD
Zalcitabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000138	0.00205	CbGpPWpGaD
Zalcitabine—SLC29A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000138	0.00205	CbGpPWpGaD
Zalcitabine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.000405	CcSEcCtD
Zalcitabine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000136	0.00202	CbGpPWpGaD
Zalcitabine—CYP3A7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000136	0.00201	CbGpPWpGaD
Zalcitabine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000399	CcSEcCtD
Zalcitabine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000397	CcSEcCtD
Zalcitabine—CYP3A7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000134	0.00198	CbGpPWpGaD
Zalcitabine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000393	CcSEcCtD
Zalcitabine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000132	0.00039	CcSEcCtD
Zalcitabine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000388	CcSEcCtD
Zalcitabine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000386	CcSEcCtD
Zalcitabine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000381	CcSEcCtD
Zalcitabine—CYP3A7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000129	0.00191	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000128	0.0019	CbGpPWpGaD
Zalcitabine—CYP3A7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.00188	CbGpPWpGaD
Zalcitabine—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000126	0.00187	CbGpPWpGaD
Zalcitabine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000125	0.00184	CbGpPWpGaD
Zalcitabine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000124	0.00184	CbGpPWpGaD
Zalcitabine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000364	CcSEcCtD
Zalcitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000123	0.00183	CbGpPWpGaD
Zalcitabine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.000363	CcSEcCtD
Zalcitabine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000361	CcSEcCtD
Zalcitabine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000119	0.000352	CcSEcCtD
Zalcitabine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000347	CcSEcCtD
Zalcitabine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.000347	CcSEcCtD
Zalcitabine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000346	CcSEcCtD
Zalcitabine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000344	CcSEcCtD
Zalcitabine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000344	CcSEcCtD
Zalcitabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000112	0.00166	CbGpPWpGaD
Zalcitabine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000329	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000327	CcSEcCtD
Zalcitabine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00011	0.00162	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000109	0.00161	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000108	0.0016	CbGpPWpGaD
Zalcitabine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000317	CcSEcCtD
Zalcitabine—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000107	0.00159	CbGpPWpGaD
Zalcitabine—SLC22A7—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000107	0.00159	CbGpPWpGaD
Zalcitabine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000316	CcSEcCtD
Zalcitabine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000316	CcSEcCtD
Zalcitabine—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000107	0.00158	CbGpPWpGaD
Zalcitabine—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000105	0.00156	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000104	0.00153	CbGpPWpGaD
Zalcitabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.0001	0.00149	CbGpPWpGaD
Zalcitabine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.99e-05	0.000294	CcSEcCtD
Zalcitabine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.91e-05	0.00147	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.81e-05	0.00145	CbGpPWpGaD
Zalcitabine—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.72e-05	0.000287	CcSEcCtD
Zalcitabine—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.68e-05	0.00143	CbGpPWpGaD
Zalcitabine—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.59e-05	0.000283	CcSEcCtD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.57e-05	0.00142	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.3e-05	0.00138	CbGpPWpGaD
Zalcitabine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	9.27e-05	0.000273	CcSEcCtD
Zalcitabine—DCK—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.19e-05	0.00136	CbGpPWpGaD
Zalcitabine—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.18e-05	0.00136	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.11e-05	0.00135	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GCLC—chronic obstructive pulmonary disease	9.08e-05	0.00135	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.08e-05	0.00135	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.05e-05	0.00134	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.03e-05	0.00134	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.98e-05	0.00133	CbGpPWpGaD
Zalcitabine—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.96e-05	0.000264	CcSEcCtD
Zalcitabine—CYP3A43—Metabolism—GCLC—chronic obstructive pulmonary disease	8.95e-05	0.00132	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.9e-05	0.00132	CbGpPWpGaD
Zalcitabine—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.62e-05	0.000254	CcSEcCtD
Zalcitabine—Rash—Prednisone—chronic obstructive pulmonary disease	8.55e-05	0.000252	CcSEcCtD
Zalcitabine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.54e-05	0.000252	CcSEcCtD
Zalcitabine—Headache—Prednisone—chronic obstructive pulmonary disease	8.49e-05	0.00025	CcSEcCtD
Zalcitabine—DCK—Metabolism—CTGF—chronic obstructive pulmonary disease	8.29e-05	0.00123	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CTGF—chronic obstructive pulmonary disease	8.16e-05	0.00121	CbGpPWpGaD
Zalcitabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.14e-05	0.00121	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.64e-05	0.00113	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.63e-05	0.00113	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.59e-05	0.00112	CbGpPWpGaD
Zalcitabine—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	7.53e-05	0.00112	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.53e-05	0.00111	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.52e-05	0.00111	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.49e-05	0.00111	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	7.49e-05	0.00111	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.43e-05	0.0011	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.16e-05	0.00106	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.08e-05	0.00105	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.98e-05	0.00103	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.92e-05	0.00102	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.88e-05	0.00102	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.86e-05	0.00102	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.82e-05	0.00101	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	6.67e-05	0.000988	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.62e-05	0.00098	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.56e-05	0.000971	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.53e-05	0.000966	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.47e-05	0.000958	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.37e-05	0.000944	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.37e-05	0.000943	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.28e-05	0.00093	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.27e-05	0.000929	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.2e-05	0.000919	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.19e-05	0.000916	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.95e-05	0.000882	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.87e-05	0.00087	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.85e-05	0.000867	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.76e-05	0.000854	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.55e-05	0.000822	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.46e-05	0.000809	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.45e-05	0.000808	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	5.32e-05	0.000788	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	5.28e-05	0.000781	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.97e-05	0.000735	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.96e-05	0.000734	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.9e-05	0.000725	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	4.82e-05	0.000714	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.56e-05	0.000676	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.5e-05	0.000666	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.48e-05	0.000664	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.33e-05	0.000641	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.27e-05	0.000632	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.83e-05	0.000567	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—ALB—chronic obstructive pulmonary disease	3.77e-05	0.000559	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.76e-05	0.000557	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—ALB—chronic obstructive pulmonary disease	3.71e-05	0.00055	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.65e-05	0.00054	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—NOS3—chronic obstructive pulmonary disease	3.61e-05	0.000534	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	3.6e-05	0.000534	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—NOS3—chronic obstructive pulmonary disease	3.55e-05	0.000526	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.53e-05	0.000522	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.5e-05	0.000518	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.48e-05	0.000515	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.47e-05	0.000513	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	3.43e-05	0.000508	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	3.4e-05	0.000504	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	3.29e-05	0.000487	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.19e-05	0.000472	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.16e-05	0.000468	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.03e-05	0.000449	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.64e-05	0.00039	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	2.6e-05	0.000386	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.53e-05	0.000374	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.52e-05	0.000373	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.49e-05	0.000369	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	2.38e-05	0.000352	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.32e-05	0.000344	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.31e-05	0.000341	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.24e-05	0.000332	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.2e-05	0.000326	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.19e-05	0.000324	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.08e-05	0.000309	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.87e-05	0.000277	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.86e-05	0.000275	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.85e-05	0.000274	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.84e-05	0.000272	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.83e-05	0.00027	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.8e-05	0.000267	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.71e-05	0.000254	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.69e-05	0.00025	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.68e-05	0.000249	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.68e-05	0.000248	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.59e-05	0.000236	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.56e-05	0.000231	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.54e-05	0.000229	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	1.5e-05	0.000222	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	1.43e-05	0.000212	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.3e-05	0.000192	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.29e-05	0.000191	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.28e-05	0.00019	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.27e-05	0.000188	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.23e-05	0.000181	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.21e-05	0.000179	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.19e-05	0.000177	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.18e-05	0.000175	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.13e-05	0.000168	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.12e-05	0.000166	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.11e-05	0.000164	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	1.08e-05	0.00016	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.03e-05	0.000153	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.02e-05	0.000151	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.49e-06	0.000126	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.37e-06	0.000124	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.8e-06	0.000116	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	7.69e-06	0.000114	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	7.62e-06	0.000113	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.4e-06	0.00011	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	7.36e-06	0.000109	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	7.29e-06	0.000108	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.03e-06	7.45e-05	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.81e-06	7.12e-05	CbGpPWpGaD
